Background The natural history of lobular carcinoma in-situ (LCIS) suggests that women are
at increased risk of subsequent invasive breast cancer. Questions of effective management …

Background Studies report low upgrade rates following excision for classic-type lobular
carcinoma in situ (LCIS) with radiologic-pathologic concordance. Thus, in the absence of …

OBJECTIVE. The objective of our study was to show the importance of surgical excision after
the diagnosis of lobular carcinoma in situ (LCIS) based on needle core biopsy. MATERIALS …

Purpose Lobular carcinoma in situ (LCIS) is a marker of increased risk of breast cancer.
Current guidelines do not recommend mastectomy as a strategy for risk reduction for most …

Introduction There is no national standard treatment for patients with breast lobular
carcinoma in situ (LCIS). Association of Breast Surgery guidelines for the management of …

Lobular carcinoma in situ (LCIS) is considered a risk factor for development of invasive
carcinoma (IC). Many variants of LCIS have been described based on pathologic features …

Background The surgical management of lobular in-situ neoplasia (LN) identified by core
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …

Lobular carcinoma in situ (LCIS) of the breast may exhibit a spectrum of morphologic growth
patterns and may also colonize underlying benign breast lesions. This diversity in …

Management of classic lobular neoplasia (cLN) diagnosed on core needle biopsy (CNB) is
controversial. Our aim in this study was to review cases of cLN diagnosed on CNB to …

Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …